Laurus Labs Ltd
NSE:LAURUSLABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Laurus Labs Ltd
NSE:LAURUSLABS
|
IN |
|
J
|
Jardine Matheson Holdings Ltd
LSE:JAR
|
HK |
|
S
|
Samsung Electronics Co Ltd
LSE:SMSN
|
KR |
|
HTC Corp
TWSE:2498
|
TW |
|
Smith Micro Software Inc
NASDAQ:SMSI
|
US |
|
Energy Recovery Inc
NASDAQ:ERII
|
US |
|
CTS Corp
NYSE:CTS
|
US |
|
BT Group PLC
XETRA:BTQ
|
UK |
|
Hino Motors Ltd
TSE:7205
|
JP |
|
Roebuck Food Group PLC
LSE:RFG
|
UK |
|
B
|
Borgwarner Inc
XBER:BGW
|
US |
|
Condor Gold PLC
LSE:CNR
|
UK |
|
Ambev SA
BOVESPA:ABEV3
|
BR |
|
Hyundai Electric & Energy Systems Co Ltd
KRX:267260
|
KR |
|
Denison Mines Corp
TSX:DML
|
CA |
|
Santana Minerals Ltd
ASX:SMI
|
AU |
Bankruptcy Probability
Laurus Labs Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Laurus Labs Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Laurus Labs Ltd
NSE:LAURUSLABS
|
750.8B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
208.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
334.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Laurus Labs Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Laurus Labs Ltd has total debt of 5.9B INR. This includes both short-term (0 INR) and long-term (5.9B INR) debt.
You can find a full breakdown on its Balance Sheet.
